Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
6
×
clinical trials
investing
6
×
life sciences
national blog main
boston top stories
boston
deals
national top stories
fda
san francisco blog main
sanofi
cancer
cancer drugs
drug discovery
ipo
new york blog main
new york top stories
roche
san francisco top stories
startups
third rock ventures
venture capital
agios pharmaceuticals
akouos
allosteric
amgen
antisense oligonucleotide
astellas pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
avapritinib
benzodiazepines
biogen
blackstone group
blackstone life sciences
blueprint medicines
brace pharma
What
medicines
6
×
drug
ipo
cancer
fda
new
research
targets
therapeutics
address
adds
affects
ago
aims
allosteric
americans
approval
approved
backed
blueprint
candidate
cause
ceo
clinic
company’s
course
currently
date
despite
developing
development
discover
disease
drugs
elusive
epilepsy
experimental
family
frequency
genes
Language
unset
Current search:
investing
×
medicines
×
" boston blog main "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds